Tipindole (INNTooltip International Nonproprietary Name), also known as typindole, is a drug of the tricyclic family described as a serotonin antagonist and monoamine oxidase inhibitor (MAOI) which was never marketed.[1][2][3][4] The drug was developed by Soviet researchers and was first described by 1962.[3]

See also

References

  1. ^ Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 1-PA287. ISBN 978-1-4757-2085-3. Retrieved 20 October 2024.
  2. ^ "Tipindole". Inxight Drugs. National Center for Advancing Translational Sciences. Retrieved 20 October 2024.
  3. ^ a b Aksanova LA, Pidevich IN, Sharkova LM, Kucherova NF (1968). "Indole derivatives". Pharmaceutical Chemistry Journal. 2 (7). Springer Science and Business Media LLC: 353–359. doi:10.1007/bf00759600. ISSN 0091-150X.
  4. ^ Ramsay RR, Gravestock MB (March 2003). "Monoamine oxidases: to inhibit or not to inhibit". Mini Reviews in Medicinal Chemistry. 3 (2): 129–136. doi:10.2174/1389557033405287. PMID 12570845. A screen using this model identified not only known MAO inhibitors (MAOI) but also similar rigid cyclic compounds such as tipindole, a 5HT receptor agonist, [...]
No tags for this post.